✦ LIBER ✦

6618 Results of a multi-center phase II study of imatinib and fluorourcail/leucovorin (FU/LV) in patients with unresectable or metastatic gallbladder or biliary tract cancer

✍ Scribed by Schuette, K.; Moehler, M.; Kettner, E.; Hegewisch-Becker, S.; Goekkurt, E.; Al-Batran, S.; Steffens, C.; Ehninger, G.; Stoehlmacher, J.

Book ID: 122420048
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 50 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71339-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of gemcitabine, oxaliplat

Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer

✍ Hezel, A F; Noel, M S; Allen, J N; Abrams, T A; Yurgelun, M; Faris, J E; Goyal, 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 277 KB

A phase II trial of gemcitabine and cape

A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202

✍ Syma Iqbal; Cathryn Rankin; Heinz-Josef Lenz; Philip J. Gold; Syed A. Ahmad; Ant 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 243 KB

Randomized Multicenter Phase II Trial of

Randomized Multicenter Phase II Trial of a Biweekly Regimen of Fluorouracil and Leucovorin (LV5FU2), LV5FU2 Plus Cisplatin, or LV5FU2 Plus Irinotecan in Patients With Previously Untreated Metastatic Gastric Cancer: A Federation Francophone de Cancerologie Digestive Group Study--FFCD 9803

✍ Bouche, O. 📂 Article 📅 2004 🏛 American Society of Clinical Oncology 🌐 English ⚖ 357 KB

PEAK: A Randomized, Multicenter Phase II

PEAK: A Randomized, Multicenter Phase II Study of Panitumumab Plus Modified Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) or Bevacizumab Plus mFOLFOX6 in Patients With Previously Untreated, Unresectable, Wild-Type KRAS Exon 2 Metastatic Colorectal Cancer

✍ Schwartzberg, L. S.; Rivera, F.; Karthaus, M.; Fasola, G.; Canon, J.-L.; Hecht, 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 520 KB